Dr. Yves Joseph Ribeill, Ph.D., founded Scynexis, Inc (NASDAQ: SCYX) and served as President from November 1999 to July 2015 and served as its Chief Executive Officer from November 1999 to April 1, 2015. Prior to organizing Scynexis, Inc. in 2000, Dr. Ribeill served various positions during the 25 years of his international career with Rhone-Poulenc, Aventis including Discovery Chemistry Group leader for Anti-Viral Research and later in the Central Nervous System Group in France. He served as Group Leader in the Cardiovascular Group in England. Upon his return to France, Dr. Ribeill served as Director of Chemistry for the Anti-Infective Group. He was involved in all phases of the drug discovery and development effort that resulted in the FDA approval of multiple drugs. He has been a Director of various Biotech companies in Europe and the US. He served as a Director of Scynexis, Inc. from November 1999 to March 16, 2016. He is the author of more than 26 publications and 15 patents. He was a member of the Scientific Advisory Committee of the World Health Organization and of the Medicine Malaria Venture in Geneva. Dr. Ribeill has a Ph.D. in Chemistry from the University of Montpellier (France).
Dan Voytas – Chief Science Officer
Dan graduated summa cum laude from Harvard College in 1984 and received his Ph.D. in genetics from Harvard Medical School in 1990. He is a co-founder of Calyxt and one of the inventors of the TALEN® technology. He continues to optimize the use of TALEN® for the targeted modification of plant genomes. In addition to his role at Calyxt, Voytas is a professor in the Department of Genetics, Cell Biology and Development at the University of Minnesota (UMN), which he joined in 2008, and os Director of the UMN’s Center for Genome Engineering. In 1992, Voytas joined the faculty at Iowa State University. Prior to this, he conducted postdoctoral research at Johns Hopkins University School of Medicine. Dan is an elected Fellow of the American Association for the Advancement of Science.
Eric Dutang – Interim Chief Financial Officer
Eric Dutang, Certified Public Accountant in France, joined Cellectis as Deputy Chief Financial Officer in May 2015. Eric began his career as financial auditor with KPMG, first in Paris for five years and then in New York for two years. He worked for publicly-traded companies in France and the U.S. including Vivendi, Veolia Environnement, and Cablevision. He then became a member of the transactions and advisory teams in Paris for seven years where he carried out acquisitions/disposals for both publicly-traded companies and private equity funds. After serving at KPMG, he worked on international business developments for French publicly-traded groups, including Air Liquide and Thales. Eric holds a Master of Finance and Executive MBA from HEC Paris (France)/Babson Massachusetts (USA).
Manoj Sahoo – Chief Commercial Officer
Manoj Sahoo joined Calyxt as Chief Commercial Officer in March 2017. He holds a MBA from the Tuck School of Business at Dartmouth and Bachelor’s degree in Chemical Engineering from the National Institute of Technology in India. Manoj has more than two decades of experience working in a variety of roles covering commercial, strategy, business development and M&A for global corporations in ag, food, energy and materials fields. Prior to joining Calyxt, Manoj was Assistant Vice President for Food Ingredients and Bio-industrial Enterprise at Cargill. At Cargill, he was responsible for revenues over $1 billion, leading the commercial enterprise team to triple its earnings from bio-based products and managing relationships with large institutional customers. His prior roles at Cargill included Business Development Director for Starches and Sweeteners North America as well as serving as an investment team member with the Emerging Business Accelerator, a group structured along corporate venture capital groups, to invest in white space opportunities for Cargill; he also worked in the Corporate Strategy & Development Group. Over the years, Manoj has also served on the boards of both Calysta Inc. and Rivertop Renewables as a Cargill representative. He was responsible for leading Cargill’s equity investments in the industrial biotechnology space including co-investment in real assets with institutional financial investors to build a $600 million commercial-scale aquaculture nutrition plant. He also serves on Industry Advisory Board of Larta Institute which assists the USDA, NIH and NSF with the commercialization assistance program.
Glenn Bowers – Vice President of Breeding
Glenn Bowers is Vice President of Breeding with responsibilities for breeding, field trialing and seed production for all crops. Glenn has a M.S. and Ph.D. degree in Plant Pathology with a focus on breeding and genetics of resistance. He spent 17 years managing a soybean breeding program with Texas A&M University, followed by a year doing the same at Purdue University. He then spent 16 years with Syngenta, first managing a soybean breeding program and then as global head of soybean breeding. He has extensive experience in Argentina and Brazil, in addition to North America. Glenn is also a certified project manager (PMP). Glenn has extensive experience in delivering products, both global and stateside, through effective collaboration with marketing and supply chain. He is skilled in creating, developing, and managing diverse and globally dispersed teams and has deep knowledge of and experience in field trialing, disease phenotyping, and agronomy.
Michel Arbadji – Director of Business Development
Michel joined Calyxt in July 2015 as Director of Business Development, and manages the external supply chain operations. Michel received his Agriculture Engineering and Master in Economics and Agriculture Machinery from the Institut National Agronomique Paris Grignon in Paris, France. Prior to joining Calyxt, Michel headed the European and Middle East Operation for Signature Control Systems, where he built and managed the distribution network, EU marketing, and sales. During that period, he served as project manager for the new business development of the European golf irrigation division at John Deere, with over 440 accounts. Michel started his career at the Toro Company EMEA, where he held several positions in business development, sales, and marketing. Over his 27-year career, he has successfully built several pioneering businesses from the R&D stage to setting up large-scale distribution channels. He has participated in several global product launches.